Introduction: Despite a safe and effective vaccine being available for more than two decades, in India, so far there has been no clear-cut policy regarding rubella immunization of children either at 15 months or young girls at child bearing age. Studies from India and abroad have found that 10-20% women in childbearing age are susceptible to rubella. Between 6-12% of babies born with congenital malformations or infections have serological evidence of rubella.
Methodology: Study was conducted in degree colleges (a health science college/medical college and a general stream). WHO rubella questionnaire was suitably modified. The questionnaire was then validated with pilot study in a group of subjects. A venous blood sample was drawn from each study subject and sent on the same day for ELISA for qualitative determination of IgG- class antibodies against rubella.
Result: Presence of over 16% susceptible college students to rubella suggests the possibility of transmission among non-immune individuals. Seropositivity to rubella antibodies was found to be higher amounts males, participants from urban area and participants belonging to high socio-economic status as compared to their counterparts.
Conclusion: There is a need for reviewing the necessity of rubella vaccination in National Immunisation Schedule.
Rubella, susceptiblity, vaccination
Using the Health Belief Model to examine travelers' willingness to vaccinate and support for vaccination requirements prior to travel.
Suess C, Maddock J, Dogru T, Mody M, Lee S
Tourism management. 2022; 88(): 104405
The behavioral immune system and vaccination intentions during the coronavirus pandemic.
Karlsson LC, Soveri A, Lewandowsky S, Karlsson L, Karlsson H, Nolvi S, Karukivi M, Lindfelt M, Antfolk J
Personality and individual differences. 2022; 185(): 111295
Modification of innate immune responses to Bordetella pertussis in babies from pertussis vaccinated pregnancies.
Rice TF, Diavatopoulos DA, Guo Y, Donaldson B, Bouqueau M, Bosanquet A, Barnett S, Holder B, Kampmann B
EBioMedicine. 2021; 72(): 103612
T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease.
Reuken PA, Andreas N, Grunert PC, GlĂ¶ckner S, Kamradt T, Stallmach A
Journal of Crohn's & colitis. 2021; ():
Awareness and Attitude Towards COVID-19 Vaccination and Associated Factors in Ethiopia: Cross-Sectional Study.
Infection and drug resistance. 2021; 14(): 2193-2199